Putting Science to Work

In the News

Syngene teams with immuno-oncology firm to provide greater value-added services

Out Sourcing Pharma- 04/06/2018. As per the partnering agreement, Syngene will screen target antigens Zumutor’s human antibody libraries to identify and characterize novel antibody clones- which it will further develop towards novel biotherapeutics programs.


This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget